Article

Educational Series on Rheumatoid Arthritis

Rheumatologists and primary care physicians will find the "Rheumatoid Arthritis Virtual Grand Rounds" to be extremely beneficial. Hosted by experts in the field, 17 patient cases will help improve the quality of care provided through patient case studies and provide new information about the available treatments for rheumatoid arthritis.

Rheumatologists and primary care physicians will find the “Rheumatoid Arthritis Virtual Grand Rounds,” brought to you by the Cleveland Clinic, to be extremely beneficial. Hosted by experts in the field, the 17 patient cases already archived and are still available for CME credit, will help improve the quality of care provided through patient case studies and provide new information about the available treatments for rheumatoid arthritis (RA).

Healthcare professionals who participate in the courses will be able to “compare and contrast biologic therapies with regard to clinical outcomes and adverse effects in patients with RA,” discuss treatments for patients with RA and comorbid conditions, explain “current evidence-based treatment using biologic therapies in RA,” and “recognize the broad implications of clinical studies over the past 10 years for clinical practice for patients with RA.”

Here are some examples of the types of courses that are available in this educational series:

Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?

Credits: 1.00

Fee: None

Expiration Date: October 30, 2010

Multimedia: Audio/Slides

Upon completing this activity, healthcare professionals will be able to discuss the risk of comorbidity, recognize risk factors for patients to develop osteoporosis and cardiovascular disease, and evaluate the risks and benefits of available rheumatoid arthritis treatments that are related to osteoporosis and CVD.

http://www.clevelandclinicmeded.com/online/webcasts/ravirtualgr/comorbidity-with-ra

The Application of New ACR Recommendations in the Management of Rheumatoid Arthritis: A Case Study Approach

Credits: 1.00

Fee: None

Expiration Date: March 30, 2010

Multimedia: Audio/Slides

Healthcare professionals who treat rheumatoid arthritis should take this course as it focuses on initial and long-term strategies for patients with “early RA in the context of the ACR Treatment Recommendations.” Featured topics include nonbiologic and biologic therapies for RA, patient management strategies, and treatment approaches based on evidence-based treatment recommendations.

http://www.clevelandclinicmeded.com/online/webcasts/ravirtualgr/ra-and-acr

Managing Rheumatoid Arthritis Patients with an Inadequate Response to TNF Inhibitors

Credits: 1.00

Fee: None

Expiration Date: May 14, 2010

Multimedia: Audio/Slides

Rheumatologists and primary care physicians who participate in this course will review the treatment options that are available to a patient with rheumatoid arthritis “who has had a lack of response to one or more biologic disease-modifying antirheumatic drugs.”

http://www.clevelandclinicmeded.com/online/webcasts/ravirtualgr/ra-and-tnf-inhibitors/default.asp

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.